CAM
KALV icon

Cormorant Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Cormorant Asset Management’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-750,000
Closed -$19.3M – 114
2021
Q1 		$19.3M Buy
+750,000
New +$19.3M 0.43% 49